Cost-Effectiveness of Empagliflozin in Combination with Standard Care versus Standard Care Only in the Treatment of Heart Failure Patients in Finland

Cost-Effectiveness of Empagliflozin in Combination with Standard Care versus Standard Care Only in the Treatment of Heart Failure Patients in Finland

Taru Hallinen,1 Santtu Kivelä,1 Erkki Soini,1 Veli-Pekka Harjola,2 Mari Pesonen3 1ESiOR Oy, Kuopio, Finland; 2Emergency Medicine, University of Helsinki, Department of Emergency Medicine and Services, Helsinki University Hospital, Helsinki, Finland; 3Boehringer Ingelheim Ky, Helsinki, FinlandCorresp...

Full description

Bibliographic Details
Main Authors: Hallinen T, Kivelä S, Soini E, Harjola VP, Pesonen M
Format: Article
Language:English
Published: Dove Medical Press 2023-01-01
Series:ClinicoEconomics and Outcomes Research
Subjects:
sodium-glucose cotransporter 2 inhibitor
cost-utility analysis
heart failure with reduced ejection fraction
heart failure with preserved ejection fraction
Online Access:https://www.dovepress.com/cost-effectiveness-of-empagliflozin-in-combination-with-standard-care--peer-reviewed-fulltext-article-CEOR

Internet

https://www.dovepress.com/cost-effectiveness-of-empagliflozin-in-combination-with-standard-care--peer-reviewed-fulltext-article-CEOR

Similar Items